Spruce Biosciences, Inc. (SPRB) stock
SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$40.49−1.76 (-4.17%)
Close on Nov 17, 2026Market cap $116.37MP/E –Yield –
Spruce Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Spruce Biosciences's price to book ratio was 1.5× on Nov 11, 2026, against 10.5× a year earlier. Over the last 5 years it ranged from 0.3× to 32.8×, with a median of 0.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.5× | −7.6 |
| 2025 | Dec 31, 2025 | 9.1× | +8.8 |
| 2024 | Dec 31, 2024 | 0.3× | −1.1 |
| 2023 | Dec 29, 2023 | 1.4× | +1.1 |
| 2022 | Dec 30, 2022 | 0.3× | −0.5 |
| 2021 | Dec 31, 2021 | 0.9× | – |
See a number that looks wrong?